Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Nersting

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Clinical Proteomics|September 13, 2011
Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemiaJacob Nersting, Louise Borst, Kjeld Schmiegelow
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 20, 2011
Liquid chromatography-tandem mass spectrometry quantification of 6-thioguanine in DNA using endogenous guanine as internal standardJack H Jacobsen, Kjeld Schmiegelow, Jacob Nersting
Immunology Letters|August 30, 2003
Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor alphaJacob Nersting, Morten Svenson, Vagn Andersen, et al.
Journal of Pediatric Hematology/Oncology|June 18, 2014
Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fictionKjeld Schmiegelow, Stine N Nielsen, Thomas L Frandsen, et al.
Cancer Chemotherapy and Pharmacology|March 20, 2015
Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemiaSophia Ingeborg Vang, Kjeld Schmiegelow, Thomas Frandsen, et al.
Journal of Pediatric Hematology/Oncology|July 8, 2014
Treatment-related myelodysplastic syndrome in a child with acute myeloid leukemia and TPMT heterozygosityLars M Stensman, Eigil Kjeldsen, Jacob Nersting, et al.
Journal of Pediatric Hematology/Oncology|August 30, 2014
Pharmacokinetics of 6-Thioguanine and 6-Mercaptopurine Combination Maintenance Therapy of Childhood ALL: Hypothesis and Case ReportStine N Nielsen, Thomas L Frandsen, Jacob Nersting, et al.
Journal of Crohn'S & Colitis|November 18, 2017
A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel DiseaseDitte V Mogensen, Jørn Brynskov, Mark A Ainsworth, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2018
Role of TPMT and ITPA variants in mercaptopurine dispositionTina Gerbek, Maria Ebbesen, Jacob Nersting, et al.
Blood|August 18, 2010
Prevalence of t(12;21)[ETV6-RUNX1]-positive cells in healthy neonatesUlrik Lausten-Thomsen, Hans Ole Madsen, Therese Risom Vestergaard, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Clinical Proteomics|September 13, 2011
Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemiaJacob Nersting, Louise Borst, Kjeld Schmiegelow
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 20, 2011
Liquid chromatography-tandem mass spectrometry quantification of 6-thioguanine in DNA using endogenous guanine as internal standardJack H Jacobsen, Kjeld Schmiegelow, Jacob Nersting
Immunology Letters|August 30, 2003
Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor alphaJacob Nersting, Morten Svenson, Vagn Andersen, et al.
Journal of Pediatric Hematology/Oncology|June 18, 2014
Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fictionKjeld Schmiegelow, Stine N Nielsen, Thomas L Frandsen, et al.
Cancer Chemotherapy and Pharmacology|March 20, 2015
Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemiaSophia Ingeborg Vang, Kjeld Schmiegelow, Thomas Frandsen, et al.
Journal of Pediatric Hematology/Oncology|July 8, 2014
Treatment-related myelodysplastic syndrome in a child with acute myeloid leukemia and TPMT heterozygosityLars M Stensman, Eigil Kjeldsen, Jacob Nersting, et al.
Journal of Pediatric Hematology/Oncology|August 30, 2014
Pharmacokinetics of 6-Thioguanine and 6-Mercaptopurine Combination Maintenance Therapy of Childhood ALL: Hypothesis and Case ReportStine N Nielsen, Thomas L Frandsen, Jacob Nersting, et al.
Journal of Crohn'S & Colitis|November 18, 2017
A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel DiseaseDitte V Mogensen, Jørn Brynskov, Mark A Ainsworth, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2018
Role of TPMT and ITPA variants in mercaptopurine dispositionTina Gerbek, Maria Ebbesen, Jacob Nersting, et al.
Blood|August 18, 2010
Prevalence of t(12;21)[ETV6-RUNX1]-positive cells in healthy neonatesUlrik Lausten-Thomsen, Hans Ole Madsen, Therese Risom Vestergaard, et al.
Pageof 5